Concord Drugs

Concord Drugs Ltd Nine Monthly Results

NSEBSE

₹30.62

(1.63%)

May 9, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Dec-2024	Dec-2023	Dec-2022	Dec-2021
Gross Sales	34.85	29.28	39.77	43.49
Excise Duty	0	0	0	0
Net Sales	34.85	29.28	39.77	43.49
Other Operating Income	0.01	0.01	0.01	0.08
Other Income	0	0	0	0
Total Income	34.86	29.29	39.78	43.57
Total Expenditure	31.76	25.59	36.17	38.56
PBIDT	3.1	3.7	3.61	5.01
Interest	1.42	1.36	1.21	1.45
PBDT	1.69	2.34	2.4	3.57
Depreciation	1.05	1.16	1.3	1.39
Minority Interest Before NP	0	0	0	0
Tax	0.2	0.42	0.32	0.62
Deferred Tax	0.14	-0.05	-0.04	-0.01
Reported Profit After Tax	0.3	0.81	0.82	1.57
Minority Interest After NP	0	0	0	0
Net Profit after Minority Interest	0.3	0.81	0.82	1.57
Extra-ordinary Items	0	0	0	0
Adjusted Profit After Extra-ordinary item	0.3	0.81	0.82	1.57
EPS (Unit Curr.)	0.3	0.81	0.94	1.79
Book Value (Unit Curr.)	0	0	0	0
Dividend (%)	0	0	0	0
Equity	10	10	8.74	8.74
Public Shareholding (Number)	0	0	0	0
Public Shareholding (%)	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0
PBIDTM(%)	8.89	12.63	9.07	11.51
PBDTM(%)	4.84	7.99	6.03	8.2
PATM(%)	0.86	2.76	2.06	3.61

No Record Found

Invest wise with Expert advice